Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Active Iron Women is an oral nutritional supplement developed by Solvotrin Therapeutics for the treatment and prevention of iron deficiency and iron deficiency anemia in women. The formulation contains 25mg of elemental iron as ferrous sulfate, encapsulated in a proprietary whey protein matrix. This delivery system is designed to protect the iron from stomach acid and target the divalent metal transporter-1 (DMT-1) in the small intestine, which is the body's natural site for iron absorption. This targeted approach is clinically shown to provide 2X better absorption compared to standard ferrous sulfate while remaining gentle on the stomach and reducing common side effects like constipation and nausea. The product is typically provided as a dual-pack containing the iron capsules and a multivitamin tablet with 17 essential vitamins and minerals, including B vitamins, folic acid, and zinc, to support energy levels, hormonal balance, and reproductive health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Active Iron Women.